Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human GRIA2 Antibodies:
anti-Rat (Rattus) GRIA2 Antibodies:
anti-Mouse (Murine) GRIA2 Antibodies:
Go to our pre-filtered search.
Dog (Canine) Monoclonal GRIA2 Primary Antibody for IHC (f), WB - ABIN967505
Huntley, Rogers, Moran, Janssen, Archin, Vickers, Cauley, Heinemann, Morrison: Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7. in The Journal of neuroscience : the official journal of the Society for Neuroscience 1993
Show all 3 Pubmed References
Human Monoclonal GRIA2 Primary Antibody for FACS, ELISA - ABIN969524
Shen, Jin: [GluR2 expression in the developing rat inferior colliculus and the relationship with development of synapse]. in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 2010
Show all 2 Pubmed References
Human Polyclonal GRIA2 Primary Antibody for IHC, IHC (p) - ABIN4314579
Leja, Essaghir, Essand, Wester, Oberg, Tötterman, Lloyd, Vasmatzis, Demoulin, Giandomenico: Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009
Show all 2 Pubmed References
Rat (Rattus) Polyclonal GRIA2 Primary Antibody for WB - ABIN361455
Murphy, Tcharnaia, Beshara, Jones: Cortical development of AMPA receptor trafficking proteins. in Frontiers in molecular neuroscience 2012
Show all 5 Pubmed References
Human Polyclonal GRIA2 Primary Antibody for IHC, WB - ABIN4274339
Lee, Su, Xie, Wang, Wan, Liu: Disrupting GluA2-GAPDH Interaction Affects Axon and Dendrite Development. in Scientific reports 2016
Rat (Rattus) Monoclonal GRIA2 Primary Antibody for IP, WB - ABIN1742378
Jedlicka, Vnencak, Krueger, Jungenitz, Brose, Schwarzacher: Neuroligin-1 regulates excitatory synaptic transmission, LTP and EPSP-spike coupling in the dentate gyrus in vivo. in Brain structure & function 2015
Rat (Rattus) Polyclonal GRIA2 Primary Antibody for IP, WB - ABIN1742379
Luchkina, Huupponen, Clarke, Coleman, Keinänen, Taira, Lauri: Developmental switch in the kinase dependency of long-term potentiation depends on expression of GluA4 subunit-containing AMPA receptors. in Proceedings of the National Academy of Sciences of the United States of America 2014
Chicken Polyclonal GRIA2 Primary Antibody for WB - ABIN2473833
Egebjerg, Kukekov, Heinemann: Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 2 Pubmed References
This study demonstrated that a significant decrease in the protein level of GluN2A (show GRIN2A Antibodies) in major depression disorder.
both the intracellular C-terminal domain (CTD) and the loop region between the M1 and M2 helices move during activation and the CTD is detached from the membrane
The results of this study suggest that neurons in hypothalamic hamartoma may bear Ca(2 (show CA2 Antibodies)+) -permeable AMPA (show GRIA3 Antibodies) receptors(GluA2 ) due to dislocation of ADAR2 (show ADARB1 Antibodies)
A transient positive feedback mechanism between AMPAR and stargazin (show CACNG2 Antibodies) has implications for information processing in the brain, because it should allow activity-dependent facilitation of excitatory synaptic transmission through a postsynaptic mechanism.
The GluR2 subunit of the AMPA (show GRIA3 Antibodies) receptor is involved in cell migration and calcium signaling.
RAB39B (show RAB39B Antibodies) selectively regulates GluA2 trafficking to determine synaptic AMPAR composition
GRIA2*CCC polymorphism is genetic risk marker for paranoid schizophrenia in Russians.Low risk genetic markers of paranoid schizophrenia were revealed: in Tatars-GRIA2*T/T (rs43025506) of GRIA2 gene and GRIA2*CCT in Russians.
GRIA2 is a useful marker for distinguishing solitary fibrous tumour from most mimics
a link between neurodegenerative processes and deficient RNA editing of the GluA2 Q/R site.
the levels were comparable for complexes containing GluR2, GluR3 (show GRIA3 Antibodies) and GluR4 (show GRIA4 Antibodies) as well as 5-HT1A (show HTR1A Antibodies). Moreover, the levels of complexes containing muscarinic AChR M1, NR1 (show GRIN1 Antibodies) and GluR1 (show GRIA1 Antibodies) were significantly increased in male patients with AD.
Results indicate that disrupting GluA2 phosphorylation and increasing GluA2-mediated transmission in the nucleus accumbens leads to increased vulnerability to cocaine relapse.
Chronic stress-elicited depressive behavior may be due to hypertrophy of basolateral amygdala (BLA (show LACTB Antibodies)) neuronal dendrites and increased of Glur1 (show GRIA1 Antibodies)-Glur2 ratio in BLA (show LACTB Antibodies) neurons.
found the protein levels of AMPA (show GRIA3 Antibodies) receptor subunits (GluR1 (show GRIA1 Antibodies) and GluR2) are upregulated in the amygdala and the 5-HT3 receptor (show HTR3A Antibodies) is downregulated in hypothalamic regions of Socially Isolated mice.
These results provide direct evidence for cortical AMPA (show GRIA3 Antibodies) receptors to contribute to zymosan-induced visceral and spontaneous pain.
Animals trained in the trace fear conditioning protocol had GluA2 RNA editing levels were nearly 100% in amygdala and hippocampus.
These results provide evidence for VPS35 (show vps35 Antibodies)'s function in promoting spine maturation, which is likely through increasing AMPA (show GRIA3 Antibodies) receptor targeting to the postsynaptic membrane.
Bacopa monnieri extract (CDRI-08) upregulates the expression of the GluR2 subunit in the CA3 (show CA3 Antibodies) area of the hippocampus.
subcellular redistribution of GRIP1 (show NCOA2 Antibodies) and a change in the binding of GRIP1 (show NCOA2 Antibodies) to GluA2 during synaptic scaling, was observed.
Data indicate that the AMPA (show GRIA3 Antibodies) receptor subunits abundance is hippocampus, GluA2 > GluA1 (show GRIA1 Antibodies) > GluA3 (show GRIA3 Antibodies) >> GluA4 (show GRIA4 Antibodies); cortex, GluA2 > GluA3 (show GRIA3 Antibodies) >/= GluA1 (show GRIA1 Antibodies) >> GluA4 (show GRIA4 Antibodies); and cerebellum, GluA2 > GluA3 (show GRIA3 Antibodies) >/= GluA1 (show GRIA1 Antibodies) > GluA4 (show GRIA4 Antibodies).
Loss of long-term potentiation was linked to reduced N-methyl-D-aspartate (NMDA) to alpha-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid (AMPA (show GRIA3 Antibodies)) current ratio.
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG\; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene.
AMPA-selective glutamate receptor 2
, Glutamate receptor 2
, glutamate receptor ionotropic, AMPA 2
, glutamate receptor 2
, glutamate receptor B
, AMPA glutamate receptor 2
, AMPA receptor GluR2/B
, AMPA selective glutamate receptor
, glutamate receptor AMPA 2